†rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

ACCOUNTSCONSOLIDATED BALANCE SHEETNote LIABILITIES 31.12.00 31.12.99(000)DKK(000)DKKShare capital 10,010 10,000Share premium 675,427 745,680Retained earnings 0 09 TOTAL SHAREHOLDER´S EQUITY 685,437 755,680Pension commitments 86,396 82,6164 Deferred tax 481,583 595,116Other provisions 110,186 1,794TOTAL PROVISIONS FOR LIABILITIES ANDCHARGES 678,165 679,526Financial institutions 2,320,740 2,567,361Mortgage debt 5,424 8,217Other long term debt 562,982 500,22610 Total long term debt 2,889,146 3,075,80410 Repayment of long term debt 136,912 156,452Financial institutions 51,351 76,912Trade payables 256,154 270,2494 Income tax payables 57,867 0Other debt 355,977 367,95311 Deferred income 145,232 0Total current liabilities 1,003,493 871,566TOTAL LIABILITIES 3,892,639 3,947,370TOTAL SHAREHOLDERS’ EQUITY ANDLIABILITIES 5,256,241 5,382,57612 Contingent liabilities, guarantee commitments etc.13 Foreign currency and interest rate risks–47–